Seelos Therapeutics Files to Sell 924K Shares of Common Stock for Holders
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersVenus Concept (NASDAQ:VERO) shares increased by 135.2% to $1.38 during Friday's pre-market session. The market value of their outstanding shares is at $8.7 million. Adlai Nortye (NASDAQ:ANL) sh
Psychedelic Stocks Fall as FDA Panel Rejects MDMA Therapy
FDA Advisory Panel Fails to Endorse Psychedelic MDMA Therapy for PTSD
Psychedelic Stocks Mixed as FDA Comments on MDMA Therapy
Seelos Therapeutics: Offering, Placement Expected to Close Around May 21 >SEEL
Seelos Therapeutics: Offering, Placement Expected to Close Around May 21 >SEEL
Express News | Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced at-the-Market Under Nasdaq Rules
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Express News | Seelos Therapeutics Shares Are Trading Higher. The Company Announced a 1-for-8 Reverse Stock Split
Seelos Therapeutics To Carry Out 1-for-8 Reverse Stock Split On May 16th, 2024
May 15th - $Seelos Therapeutics(SEEL.US)$ is about to implement a 1-for-8 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from May 16th, 2024.$Seelos Therapeutic
Seelos Therapeutics: Reverse Split Aimed at Regaining Compliance With Nasdaq Minimum Bid Price Requirement >SEEL
Seelos Therapeutics: Reverse Split Aimed at Regaining Compliance With Nasdaq Minimum Bid Price Requirement >SEEL
Express News | Seelos Therapeutics Announces 1-for-8 Reverse Stock Split
Seelos Therapeutics: Shares to Begin Trading on Split-Adjusted Basis at Open of Market on May 16 >SEEL
Seelos Therapeutics: Shares to Begin Trading on Split-Adjusted Basis at Open of Market on May 16 >SEEL
Seelos Therapeutics | 10-Q: Quarterly report
"FDA Expert Committee Will Review MDMA-Assisted Therapy For PTSD Next Month" - Marijuana Moment
The Food and Drug Administration (FDA) is taking the next step in its historic review of MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD), scheduling a meeting next mon
Express News | On April 30, Seelos Therapeutics Inc Announced A Reduction In Its Workforce That Affected ~33% Of Its Current Employees; Company Received Bid Notice From Nasdaq Stock Market
Seelos Therapeutics Navigates Financial and Board Changes
Express News | Seelos Therapeutics Inc - on April 30, 2024, Company Received Bid Notice From Nasdaq Stock Market LLC
Express News | Seelos Therapeutics Inc - on April 30, Announced a Reduction in Its Workforce That Affected Approximately 33% of Its Current Employees
12 Health Care Stocks Moving In Monday's After-Market Session
GainersGeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday's after-market session. The market value of their outstanding shares is at $349.1 million. The company's, Q1 earnings
No Data